HKSE - Delayed Quote HKD
TOT BIOPHARM-B (1875.HK)
1.880
-0.020
(-1.05%)
At close: May 9 at 3:45:00 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
116,403
116,403
56,431
59,929
-175,137
Investing Cash Flow
-122,505
-122,505
-164,105
-282,764
-108,393
Financing Cash Flow
34,183
34,183
38,225
481,240
212,082
End Cash Position
381,256
381,256
351,600
417,769
152,805
Capital Expenditure
-123,574
-123,574
-203,200
-240,123
-115,313
Issuance of Capital Stock
541,952
--
0
405,788
1,990
Issuance of Debt
267,823
267,823
132,152
277,858
205,966
Repayment of Debt
-218,095
-218,095
-75,500
-196,191
0
Free Cash Flow
-7,171
-7,171
-146,769
-180,194
-290,450
12/31/2021 - 11/8/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1167.HK JACOBIO-B
3.960
+8.79%
IRON Disc Medicine, Inc.
44.24
-0.11%
6696.TWO Lin BioScience, Inc.
118.00
-0.84%
NKTX Nkarta, Inc.
1.9300
-1.03%
VYGR Voyager Therapeutics, Inc.
3.1700
-7.58%
6733.TWO BioGend Therapeutics Co., Ltd.
28.35
-0.35%
6535.TWO Lumosa Therapeutics Co., Ltd.
157.00
-0.32%
ITRM Iterum Therapeutics plc
1.0200
-2.86%
4728.TWO Sunmax Biotechnology Co., Ltd.
466.50
-2.00%
1762.TW Chunghwa Chemical Synthesis & Biotech Co., Ltd.
29.40
0.00%